Adding Liver-Directed Therapy to Immunotherapy Doubles Survival in Advanced Liver Cancer
A two-center retrospective study found that adding TACE or HAIC to targeted-immunotherapy nearly doubled median overall survival in advanced hepatocellular ...
A two-center retrospective study found that adding TACE or HAIC to targeted-immunotherapy nearly doubled median overall survival in advanced hepatocellular ...
A nationwide survey of 120 senior Chinese specialists reveals that over half of newly diagnosed intermediate-stage liver cancer patients are ...
Researchers found that liver cancer patients who responded poorly to conversion therapy harbored distinct bacterial communities inside their tumors, including ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine